ATC codes:
J01DD04
EMLc
Indication
Bacterial meningitis
ICD11 code:
8E71.0Z
INN
Ceftriaxone
Medicine type
Chemical agent
Antibiotic groups
List type
Core
(EML)
(EMLc)
(EMLc)
Additional notes
Do not administer with calcium and avoid in infants with hyperbilirubinaemia.
Formulations
Parenteral > General injections > unspecified:
250 mg in vial powder for injection (as sodium salt) ;
1 g in vial powder for injection (as sodium salt) ;
2 g in vial powder for injection (as sodium salt) (EML)
;
500 mg in vial powder for injection (as sodium salt)
EML status history
Sex
All
Age
Also recommended for children
Age restriction
> 41 weeks corrected gestational age
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Expert Committee recommendation
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of new strength formulations of cefotaxime (powder for injection: 500 mg; 1 g; 2 g (as sodium) in vial) to the EML and EMLc.
- the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc.
- the addition of new formulations of amoxicillin (dispersible, scored tablet, 250 mg and 500 mg) to the EMLc.
- the deletion of oral formulations of chloramphenicol (capsule 250 mg and oral liquid 150 mg/5 mL (as palmitate)) from the EML and EMLc.
EML recommendations: Bacterial meningitis
First choice
Second choice
First choice
Second choice